We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

174 hedge funds and large institutions have $1.41B invested in Dr. Reddy's Laboratories in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

10% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 58

9% more capital invested

Capital invested by funds: $1.3B → $1.41B (+$111M)

4% more funds holding

Funds holding: 168174 (+6)

3.37% less ownership

Funds ownership: 75.89%72.52% (-3.4%)

Holders
174
Holders Change
+6
Holders Change %
+3.57%
% of All Funds
4.64%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
23
Increased
64
Reduced
58
Closed
15
Calls
$58K
Puts
Net Calls
+$58K
Net Calls Change
+$58K
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
126
Creative Planning
Kansas
$360K +$12.7K +1,200 +4%
LNWWM
127
Laird Norton Wetherby Wealth Management
California
$329K +$3.92K +370 +1%
Jane Street
128
Jane Street
New York
$322K -$2.83M -266,855 -90%
CG
129
Colony Group
Massachusetts
$317K +$46.9K +4,420 +19%
California Public Employees Retirement System
130
California Public Employees Retirement System
California
$305K
RBC
131
Ronald Blue & Co
Georgia
$295K -$79.8K -7,520 -23%
PNC Financial Services Group
132
PNC Financial Services Group
Pennsylvania
$294K +$125K +11,820 +85%
Envestnet Asset Management
133
Envestnet Asset Management
Illinois
$279K +$197K +18,530 +312%
OC
134
Oppenheimer & Co
New York
$270K -$5.3K -500 -2%
B
135
Bailard
California
$260K -$1.33M -125,100 -83%
HNB
136
Huntington National Bank
Ohio
$255K +$5.94K +560 +3%
Janus Henderson Group
137
Janus Henderson Group
United Kingdom
$250K -$308K -29,000 -57%
1GA
138
1st Global Advisors
Texas
$241K +$3.66K +345 +2%
NFA
139
Nationwide Fund Advisors
Ohio
$228K -$1.11M -105,000 -84%
Renaissance Technologies
140
Renaissance Technologies
New York
$228K +$212K +20,000 New
Mirae Asset Global Investments
141
Mirae Asset Global Investments
South Korea
$227K +$211K +19,905 New
CCA
142
Checchi Capital Advisers
California
$212K +$197K +18,595 New
Calamos Advisors
143
Calamos Advisors
Illinois
$205K +$190K +17,950 New
GT
144
Glenmede Trust
Pennsylvania
$122K
MIP
145
Mondrian Investment Partners
United Kingdom
$120K +$37.1K +3,500 +50%
RFS
146
Rockefeller Financial Services
New York
$94K
H
147
Hexavest
Quebec, Canada
$80K -$52.7K -4,965 -41%
MFBTD
148
MB Financial Bank - Trust Department
Illinois
$75K
MTB
149
Mizuho Trust & Banking
Japan
$72K +$67.3K +6,340 New
CLOS
150
Compagnie Lombard Odier SCmA
Switzerland
$47K

RDY Hedge Fund Activity: Q1 2015 in Review

174 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2015, worth a combined $1.41B — up 8.5% from $1.3B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new RDY positions and 15 closed out — a net gain of 8 holders — while 64 added to existing stakes and 58 trimmed.

The largest buyer was Fisher Asset Management, adding an estimated $56.4M. The largest seller was Fidelity International, cutting an estimated $34.8M.

  • 174 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2015, up from 168 in Q4 2014.
  • Funds reported $1.41B of Dr. Reddy's Laboratories stock for Q1 2015, up 8.5% quarter-over-quarter.
  • 23 funds opened new Dr. Reddy's Laboratories positions in Q1 2015 and 15 closed out, a net change of +8 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2015 was Fisher Asset Management, an estimated $56.4M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2015 was Fidelity International, an estimated $34.8M sold.

Based on aggregated 13F filings for Q1 2015.